healthcare

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares jumped sharply on Thursday after the firm announced that it has in-licensed a Phase 2 asset, TNX-1300 for the treatment of cocaine intoxication. ... Read Full Story »

Ocular Therapeutix Inc. (NASDAQ: OCUL) shares took a beating on Tuesday after the firm announced late-stage results for patients with primary open-angle glaucoma or ocular hypertension. These results come from ... Read Full Story »

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) shares were absolutely crushed in Tuesday’s session after the company announced late-stage results for its study in hereditary angioedema (HAE) patients. Specifically, the firm announced ... Read Full Story »

Amyris Inc. (NASDAQ: AMRS) shares jumped early on Monday on news that the firm had received its first payment from its cannabinoid partner. Specifically, Amyris received $10 million from Lavvan ... Read Full Story »

Duchenne muscular dystrophy (DMD) is an inherited disorder of progressive muscular weakness, especially in boys. It affects one out of 3,500 to 5,000 males worldwide and is one of the ... Read Full Story »

The 55th annual meeting of the American Society of Clinical Oncology (ASCO) is just around the corner. Biotech and pharmaceutical companies will descend on Chicago for a five-day all-out conference ... Read Full Story »

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ... Read Full Story »

The short interest data are out for the most recent settlement date, April 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ... Read Full Story »

With evolving societal and regulatory landscapes, the upside potential of cannabis as a new investment strategy has emerged to complement the historically resilient characteristics of alcohol and tobacco. Cannabis stocks ... Read Full Story »

When Mylan N.V. (NASDAQ: MYL) released its first-quarter financial results before the markets opened on Tuesday, the company posted $0.82 in earnings per share (EPS) and $2.5 billion in revenue. ... Read Full Story »